Filing Flows › Medpace Holdings (MEDP) › Q3 2026
Medpace Holdings (MEDP) Q3 2026 earnings results (third quarter 2026)
10-Q filed Oct 22, 2026
Medpace Holdings (MEDP) reported revenue of $716M for the third quarter 2026 (Q3 2026), +9% from a year earlier and +1% from the quarter before. Operating margin was 23.1%, net earnings $137M (19.2% of revenue).
Medpace Holdings, Q3 2026: revenue $716M (+8% year over year), operating margin 23.1%, net earnings $137M, operating cash flow $217M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $716M | +1% | +9% |
| Operating profit | $166M | +13% | +17% |
| Net earnings | $137M | +13% | +24% |
| Operating cash flow | $217M | +34% | -12% |
| Free cash flow | $196M | +42% | -17% |
What changed
Revenue was $716.0M in Q3 2026, up 9% year over year and up 1% from the previous quarter. Metabolic was the largest line at 32% of revenue. Metabolic added $37.3M year over year (up 19%), 66% of the total change. AVAI declined 13%.
Operating profit was $165.5M, a 23.1% margin (up 1.6 points year over year). Of the extra revenue versus Q3 2025, 42% reached operating profit, above the 21% margin then. Total costs grew 6% against revenue growth of 9%. Net earnings were $137.5M, up 24% year over year. The effective tax rate was 19.6%.
Operating cash flow was $216.6M (down 12% year over year), 158% of net earnings. Non-cash charges added back $6.6M of depreciation and amortization and $7.6M of share-based compensation. Working capital and other items added $65.0M. Capital expenditures of $20.2M left free cash flow of $196.4M.
Questions
What was Medpace Holdings' revenue in the third quarter 2026?
Medpace Holdings (MEDP) reported revenue of $716M for the third quarter 2026 (Q3 2026), +9% from a year earlier and +1% from the quarter before.
Was Medpace Holdings profitable in the third quarter 2026?
Operating profit was $166M (23.1% of revenue) and net earnings $137M.
Source: Medpace Holdings 10-Q on SEC EDGAR.